Clinical Scorecard: Incidence and Outcomes of Non-Dilated Left Ventricular Cardiomyopathy in Patients Undergoing Cardiac MRI
At a Glance
Category
Detail
Condition
Non-Dilated Left Ventricular Cardiomyopathy (NDLVC)
Key Mechanisms
Characterized by left ventricular hypokinesia without dilatation and/or presence of non-ischemic late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR)
Target Population
Patients undergoing CMR for myocardial perfusion or viability assessment, aged >18 years without prior myocardial infarction or coronary revascularization
Care Setting
Cardiology and radiology departments utilizing cardiac MRI for cardiomyopathy evaluation
Key Highlights
ESC guidelines recommend contrast-enhanced CMR as the initial and ongoing assessment tool for suspected cardiomyopathies, including NDLVC.
NDLVC is defined by non-ischemic LGE with or without LV hypokinesia, distinct from dilated cardiomyopathy (DCM).
Prognostic value of LV global longitudinal strain (LV-GLS) and left atrial strain (LAS) via CMR feature-tracking is established in cardiovascular disease.
Guideline-Based Recommendations
Diagnosis
Use contrast-enhanced CMR as the primary diagnostic modality for suspected cardiomyopathies (Class I recommendation).
Identify late gadolinium enhancement (LGE) patterns to aid cardiomyopathy phenotyping.
Classify cardiomyopathies based on morpho-functional phenotypes including NDLVC, DCM, HCM, ARVC, and restrictive cardiomyopathy.
Management
Adopt a cardiomyopathy-focused approach guided by CMR findings for patient evaluation and treatment planning.
Monitor disease progression and guide management using serial CMR assessments including strain analysis.
Monitoring & Follow-up
Perform ongoing CMR evaluations to monitor disease progression, risk stratification, and management guidance (Class IIa recommendation).
Utilize LV-GLS and LAS measurements from CMR feature-tracking for prognostic assessment.
Risks
Exclude ischemic cardiomyopathy by ruling out ischemic LGE patterns and myocardial perfusion defects.
Recognize that prognosis differences between NDLVC and DCM remain to be fully elucidated.
Patient & Prescribing Data
Adults undergoing CMR for myocardial perfusion or viability assessment excluding ischemic heart disease and other cardiomyopathies
NDLVC patients identified by CMR may require tailored monitoring and management distinct from DCM, though prognostic implications need further study.
Clinical Best Practices
Perform comprehensive CMR including cine imaging, LGE, T1 mapping, and feature-tracking strain analysis for accurate cardiomyopathy phenotyping.
Exclude patients with ischemic LGE, prior myocardial infarction, or isolated LV dilatation without reduced ejection fraction to refine diagnosis.
Use standardized definitions for cardiovascular risk factors to contextualize patient risk profiles.
Interpret CMR data by experienced clinicians with expertise in cardiomyopathy imaging.
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
